Arrowhead Pharmaceuticals
ARWR
#1909
Rank
HK$86.84 B
Marketcap
HK$620.17
Share price
5.62%
Change (1 day)
511.67%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): HK$2.66

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$2.74. an increase over its 2024 EPS that were of -HK$39.18.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-HK$0.07836-99.8%
2024-HK$39.18161.39%
2023-HK$14.9917.36%
2022-HK$12.7719.85%
2021-HK$10.6661.9%
2020-HK$6.58-216.67%
2019HK$5.64-210.77%
2018-HK$5.0938.3%
2017-HK$3.68-64.93%
2016-HK$10.50-16.25%
2015-HK$12.5428%
2014-HK$9.80-3.85%
2013-HK$10.19-31.58%
2012-HK$14.89331.82%
2011-HK$3.45-51.11%
2010-HK$7.05-79.07%
2009-HK$33.70-37.68%
2008-HK$54.07-16.87%
2007-HK$65.0438.33%
2006-HK$47.02122.22%
2005-HK$21.1642.11%
2004-HK$14.89533.33%
2003-HK$2.35-99.08%
2002-HK$254.4325%
2001-HK$203.5433.33%
2000-HK$152.66-120%
1999HK$763.29-400%
1998-HK$254.43-81.48%
1997-HK$1,374

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29 3,082.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$56.97-2,177.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$49.37 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$14.11 414.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$22.57-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA